Ibritumomab Tiuxetan and Von Willebrand Factor
Determining the interaction of Ibritumomab Tiuxetan and Von Willebrand Factor and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab
Generic Name: antihemophilic factor / von willebrand factor
Brand name: Alphanate, Humate-P, Wilate, Wilstart, Dried Factor VIII Fraction Type 8Y, Haemate P, Optivate
Synonyms: Antihemophilic and von Willebrand factor complex, Antihemophilic Factor/von Willebrand Factor Complex (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Tiuxetan-Von Willebrand factor recombinant
- Ibritumomab Tiuxetan-Von willebrand factor recombinant Intravenous
- Ibritumomab Tiuxetan-Vonvendi
- Ibritumomab Tiuxetan-Vopac
- Ibritumomab Tiuxetan-Vopac MDS
- Ibritumomab Tiuxetan-Vorapaxar
- Von Willebrand Factor-Ibrutinib
- Von Willebrand Factor-Ibrutinib Capsules
- Von Willebrand Factor-Ibrutinib Tablets
- Von Willebrand Factor-Ibu
- Von Willebrand Factor-IBU Tablets
- Von Willebrand Factor-Ibu-2